Top 20 global biopharma companies report 4.3% growth in market capitalisation in Q2 2024, reveals GlobalData Read more
Obesity drug tirzepatide approval in China strengthens market position amid GLP-1 agonist competition: GlobalData Read more
FINEARTS-HF trial results in clinically meaningful reduction in the composite endpoint of CV death Read more
NewAmsterdam’s obicetrapib holds potential to become first CETP inhibitor to advance to clinical practice: GlobalData Read more
Diagnosed prevalent cases of chronic kidney disease to reach 22.97 million across 7MM in 2033, predicts GlobalData Read more
Synergistic safety profile could increase sublingual apomorphine competitiveness: GlobalData Read more
Prioritised investments from pharma companies shaping competitive pipeline landscape of bronchiectasis: GlobalData Read more
VNS and cenobamate combo therapy success paves way for cenobamate monotherapy, says GlobalData Read more